Allergen SA appoints new country manager
Morné Steenkamp has been appointed country manager of Allergan South Africa, a subsidiary of US-based Allergan Inc., a global multi-speciality health care company with portfolios in eye care, neurosciences, medical dermatology, medical aesthetics and breast prostheses.
Morne Steenkamp
Steenkamp takes on the position from 1 May 2013, reporting to Sanjiv Patel, Vice President, Emerging Markets. Steenkamp succeeds Gerald Seftel who was Allergan South Africa's first employee in 1983 and built the organisation's presence in South Africa from scratch.
Steenkamp joined Allergan in 2009 as head of the Ophthalmology business, built up a dynamic team and created a positive growth trajectory for the division, including one of the world's highest market share in 'tears' products. He then moved on to head the Medical and Neuroscience businesses in 2011, where he had overall responsibility for the distribution and marketing of products such as facial injectables, dermal fillers and breast implants.
"Morné has built successful businesses in all our franchises focusing on building teams to leverage the large potential of the local markets," says Seftel, who is retiring from the Country Manager role.
Prior to working at Allergan, Steenkamp worked for Boston Scientific in both South Africa and the USA. He holds a PhD from the University of Pretoria.
"Over the past two years, we have built a robust succession plan," says Seftel. "Allergan's sales continue to grow in South Africa and Morné is well equipped to drive the company's future growth."
"[W]e look forward to [Seftel] continuing to work with Allergan as chair of the South African legal entity and with him on specific projects for the emerging market team," says Steenkamp.
